Jjy Healthcare Limited 10188152 true 2023-06-01 2024-05-31 2024-05-31 The principal activity of the company is Other human health activities Digita Accounts Production Advanced 6.30.9574.0 true Mrs Jayshree Jagdeo true 10188152 2023-06-01 2024-05-31 10188152 2024-05-31 10188152 bus:CompanySecretaryDirector1 1 2024-05-31 10188152 bus:OrdinaryShareClass1 2024-05-31 10188152 core:RetainedEarningsAccumulatedLosses 2024-05-31 10188152 core:ShareCapital 2024-05-31 10188152 core:CurrentFinancialInstruments 2024-05-31 10188152 core:CurrentFinancialInstruments core:WithinOneYear 2024-05-31 10188152 bus:FRS102 2023-06-01 2024-05-31 10188152 bus:AuditExempt-NoAccountantsReport 2023-06-01 2024-05-31 10188152 bus:FullAccounts 2023-06-01 2024-05-31 10188152 bus:RegisteredOffice 2023-06-01 2024-05-31 10188152 bus:CompanySecretaryDirector1 2023-06-01 2024-05-31 10188152 bus:CompanySecretaryDirector1 1 2023-06-01 2024-05-31 10188152 bus:OrdinaryShareClass1 2023-06-01 2024-05-31 10188152 bus:EntityNoLongerTradingButTradedInPast 2023-06-01 2024-05-31 10188152 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 10188152 countries:England 2023-06-01 2024-05-31 10188152 bus:CompanySecretaryDirector1 1 2023-05-31 10188152 2023-05-31 10188152 bus:CompanySecretaryDirector1 1 2023-05-31 10188152 bus:OrdinaryShareClass1 2023-05-31 10188152 core:RetainedEarningsAccumulatedLosses 2023-05-31 10188152 core:ShareCapital 2023-05-31 10188152 core:CurrentFinancialInstruments 2023-05-31 10188152 core:CurrentFinancialInstruments core:WithinOneYear 2023-05-31 10188152 bus:CompanySecretaryDirector1 1 2022-06-01 2023-05-31 10188152 bus:CompanySecretaryDirector1 1 2022-05-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 10188152

Jjy Healthcare Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 May 2024

 

Jjy Healthcare Limited

Profit and Loss Account for the Year Ended 31 May 2024

The company has not traded during the year. During this year, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

 

Jjy Healthcare Limited

(Registration number: 10188152)
Balance Sheet as at 31 May 2024

Note

2024
£

2023
£

Current assets

 

Debtors

3

1,305

1,305

Cash at bank and in hand

 

837

837

 

2,142

2,142

Creditors: Amounts falling due within one year

5

(1,497)

(1,497)

Net assets

 

645

645

Capital and reserves

 

Called up share capital

6

1

1

Retained earnings

644

644

Shareholders' funds

 

645

645

For the financial year ending 31 May 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

Approved and authorised by the director on 19 March 2025
 

.........................................
Mrs Jayshree Jagdeo
Company secretary and director

 

Jjy Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
6 Midwinter Close
Tilehurst
Reading
RG30 6HZ
England

These financial statements were authorised for issue by the director on 19 March 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Jjy Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2024

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Debtors

Current

2024
£

2023
£

Other debtors

1,305

1,305

 

1,305

1,305

4

Cash and cash equivalents

2024
£

2023
£

Cash at bank

837

837

5

Creditors

Note

2024
£

2023
£

Due within one year

 

Social security and other taxes

 

588

588

Income tax liability

909

909

 

1,497

1,497

6

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary of £1 each

1

1

1

1

       
 

Jjy Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2024

7

Related party transactions

 

Jjy Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2024

Transactions with the director

2024

At 1 June 2023
£

At 31 May 2024
£

Mrs Jayshree Jagdeo

Advance

1,305

1,305

2023

At 1 June 2022
£

Advances to director
£

At 31 May 2023
£

Mrs Jayshree Jagdeo

Advance

-

1,305

1,305